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The publication of the 1996 Report of the Comiti. de 
I’Antibiogramme de la SociCtC Franqaise de Micro- 
biologie in English [l] gives those of us who have 
difficulty with the nuances of the French language 
an opportunity to compare the susceptibility testing 
methods described with those of others. Those who are 
not persuaded of the dificulty may like to consider the 
difference in meaning of the words ‘antibiogramme’ 
and ‘antibiogram’! 
We wish to draw attention to three features that 
in our opinion are important when comparisons are 
made, relating to the medium used, the inoculum, 
and interpretation. The French use Mueller-Hinton 
medium for general susceptibility testing, unlike the 
Swedes, who use PDM Antibiotic Sensitivity Medium 
(AB Biodisc), and the British, who use a variety of 
media, of which IsoSensitest (Oxoid) is very similar to 
PDM [2]. However, this does not mean that the French 
methology is ‘essentially NCCLS’, as some have con- 
cluded. A major difference is the inoculum size used 
for disk testing, presumably based on the work done by 
Chabbert for the International Collaborative Study of 
the 1960s [3], which is similar to that producing semi- 
confluent growth advocated in the UK [2], and thus 
some 100-fold lighter than that used in the NCCLS 
method [4]. Since the French (unlike the British) tend 
to use high-content disks (like NCCLS), the sizes of 
zones of inhibition should be larger, and examination 
of breakpoints for disk tests shows that this is often 
the case. However, this simplistic deduction has to be 
qualified by Chabbert’s clear statement [5] that the 
setting of breakpoints is a matter for national authorities. 
A quick analysis shows that the lower MIC breakpoints 
tend towards the low values used in the UK-pre- 
sumably reflecting a concern that organisms with 
any kind of resistance mechanism should command 
respect-while the higher breakpoints are closer to 
those of NCCLS-presumably reflecting confidence 
in high dosage as a means of overcoming these mech- 
anisms. These two factors lead to the wider range of 
intermediate susceptibility often found in the French 
recommendations, and since they are derived from 
MICs, breakpoints for disk tests also tend to have wider 
intermediate susceptibility ranges. 
How does all this help the cause of international 
standardization? As far as the medium is concerned, 
those who do not use Mueller-Hinton medium will 
find it even more difficult to persuade those who do 
that they are wrong! The same probably applies to 
high-content disks, which lead either to the use of 
larger (and thus more expensive) Petri dishes or to the 
acceptance of overlapping zones (albeit not without 
interest). However, the French would seem to join the 
minority party in using a lighter inoculum. It has always 
seemed to us that fruitless argument could be avoided 
by studes that demonstrate the essential superimpos- 
ability of results (with or without correcting factors) 
derived from such variations in technique, and that 
attempts to impose one technique on the unwilling are 
not justified. It is much more difficult to deal with the 
contention that breakpoints should be set at a national 
level. The reasons why ‘clinical interpretation seemed 
too controversial at  the international level’ to those 
who attempted standardization in the 1960’s [3] need 
to be examined again in the hope that pragmatic 
consensus may now be attainable. Courvalin’s advocacy 
for interpretive reading of susceptibility testing results 
[6], a practice that we have used for many years, should 
provide a new opportunity for us to reopen those 
discussions. None of this belittles the role of national 
societies in improving the quality and relevance of 
susceptibility tests, in which the French Society 
continues to lead. 
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